ACAD
39.56
+0.42
+1.07%
AEMD
3.75
-0.06
-1.52%
APRI
3.08
-0.06
-1.91%
ARNA
1.42
0.00
0.00%
ATEC
3.27
+0.15
+4.81%
CNAT
4.82
0.00
0.00%
CRXM
0.214
-0.006
-2.5011%
CYTX
1.78
+0.01
+0.56%
DXCM
77.96
-0.63
-0.80%
GNMK
10.94
+0.14
+1.30%
HALO
12.04
-0.03
-0.25%
ILMN
161.01
-1.29
-0.79%
INNV
0.155
-0.005
-3.125%
INO
6.9
+0.3
+4.55%
ISCO
1.35
+0.33
+32.35%
ISIS
57.56
0.00
0.00%
LGND
102.84
-0.43
-0.42%
LPTN
2.93
0.00
0.00%
MBVX
3.07
+0.26
+9.25%
MEIP
1.69
-0.01
-0.59%
MNOV
6
-0.02
-0.33%
MRTX
5.7
-0.05
-0.87%
MSTX
0.123
-0.002
-1.5200%
NBIX
43.08
+0.48
+1.13%
NUVA
74.51
+0.95
+1.29%
ONCS
1.42
-0.1
-6.58%
ONVO
2.97
0.00
0.00%
OREX
3.98
-0.22
-5.24%
OTIC
14.95
-0.2
-1.32%
QDEL
21.41
+0.19
+0.90%
RCPT
231.96
0.00
0.00%
RGLS
1.05
-0.03
-2.33%
RMD
71.62
-0.76
-1.05%
SPHS
2.63
+0.02
+0.77%
SRNE
5.2
-0.05
-0.95%
TROV
2
-0.05
-2.44%
VICL
2.15
-0.04
-1.83%
VOLC
18
0.00
0.00%
ZGNX
10.6
-0.25
-2.30%
ACAD
39.56
+0.42
+1.07%
AEMD
3.75
-0.06
-1.52%
APRI
3.08
-0.06
-1.91%
ARNA
1.42
0.00
0.00%
ATEC
3.27
+0.15
+4.81%
CNAT
4.82
0.00
0.00%
CRXM
0.214
-0.006
-2.5011%
CYTX
1.78
+0.01
+0.56%
DXCM
77.96
-0.63
-0.80%
GNMK
10.94
+0.14
+1.30%
HALO
12.04
-0.03
-0.25%
ILMN
161.01
-1.29
-0.79%
INNV
0.155
-0.005
-3.125%
INO
6.9
+0.3
+4.55%
ISCO
1.35
+0.33
+32.35%
ISIS
57.56
0.00
0.00%
LGND
102.84
-0.43
-0.42%
LPTN
2.93
0.00
0.00%
MBVX
3.07
+0.26
+9.25%
MEIP
1.69
-0.01
-0.59%
MNOV
6
-0.02
-0.33%
MRTX
5.7
-0.05
-0.87%
MSTX
0.123
-0.002
-1.5200%
NBIX
43.08
+0.48
+1.13%
NUVA
74.51
+0.95
+1.29%
ONCS
1.42
-0.1
-6.58%
ONVO
2.97
0.00
0.00%
OREX
3.98
-0.22
-5.24%
OTIC
14.95
-0.2
-1.32%
QDEL
21.41
+0.19
+0.90%
RCPT
231.96
0.00
0.00%
RGLS
1.05
-0.03
-2.33%
RMD
71.62
-0.76
-1.05%
SPHS
2.63
+0.02
+0.77%
SRNE
5.2
-0.05
-0.95%
TROV
2
-0.05
-2.44%
VICL
2.15
-0.04
-1.83%
VOLC
18
0.00
0.00%
ZGNX
10.6
-0.25
-2.30%
Home » Archive by Category

Xconomy

Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More

November 18, 2016 – 4:30 am

Speculation swirled this week around the incoming U.S. president’s intent to make good on his angry campaign rhetoric on drug prices, while the Associated Press reported that…

[[Click headline to continue reading.]]

How to Lower Drug Prices, Improve Care, and Save Pharma

November 16, 2016 – 10:52 pm

I recently received a note from a longtime friend who questioned me on the issue of pharma pricing. I answered with the always-reliable…

[[Click headline to continue reading.]]

Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More

November 11, 2016 – 1:00 am

The presidential election ended with Donald Trump’s stunning victory and Republican retention of the House and Senate. Now, the U.S. healthcare sector will try to figure out what it all means. Drug…

[[Click headline to continue reading.]]

Trump Team Outlines Healthcare Agenda—No Mention of Drug Prices

November 10, 2016 – 1:25 pm

The incoming Trump administration has posted an outline of its healthcare agenda on its transition website. There is no mention of drug pricing or what the administration might do about frequent…

[[Click headline to continue reading.]]

In Trump-GOP Tsunami, Blue-State Healthcare Ideas Swamped

November 9, 2016 – 7:56 am

[Updated, 11/9/16, 1:20 p.m. See below.] The 2016 U.S. election is over. The country has been rocked by the presidential race, with Donald Trump taking the White House. Every facet of American…

[[Click headline to continue reading.]]

Forecast Update: CA’s Prop. 61 Now A Toss-Up, New Poll Shows

November 7, 2016 – 1:02 pm

Xconomy reported Thursday that support for Proposition 61, the California initiative to rein in drug prices, had slipped in a recent poll to a slim 51 percent majority, with 24 percent opposed and 25…

[[Click headline to continue reading.]]

Forecast Update: CA’s Prop. 61 Now A Toss-Up, New Poll Shows

November 7, 2016 – 1:02 pm

Xconomy reported Thursday that support for Proposition 61, the California initiative to rein in drug prices, had slipped in a recent poll to a slim 51 percent majority, with 24 percent opposed and 25…

[[Click headline to continue reading.]]

New Data Show Biogen, Ionis Drug Might Help More With Rare Spine Disease

November 7, 2016 – 7:43 am

Up until this point, studies of an experimental drug from Biogen and Ionis Pharmaceuticals had focused on patients with the most severe form of a rare, potentially deadly genetic disorder called…

[[Click headline to continue reading.]]

Sanofi’s Experience With Dengvaxia May Speed Development of Zika Vaccine

November 4, 2016 – 5:59 am

Dengvaxia, the first licensed vaccine for dengue virus, has now been approved in 11 countries where dengue is endemic. But sales of the vaccine, which were initially projected to reach €200 million…

[[Click headline to continue reading.]]

Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More

November 4, 2016 – 4:26 am

Our previous roundup came out last week before news broke that Susan Lindquist, a highly decorated and thoughtful researcher into the inner workings of proteins, passed away. She was 67. First at the…

[[Click headline to continue reading.]]